A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes
{{output}}
The clinical application of cancer stem cell marker CD44 in breast cancer prognosis has been widely explored. However, data on the association between CD44 expression and prognostication across molecular subtypes of breast cancer remain limited. In this study ... ...
